Advertisement
Death within five years of first unplanned hospital admission is common among older adults

Five-Year Mortality Up in Older Adults With Unplanned Admission

0
Among seniors, just over half of all deaths occurred in those with first unplanned hospital admission
Non-breast cancer (non-BC) causes of death represent a considerable proportion of deaths among patients diagnosed with BC

Many Long-Term Breast Cancer Survivors Die From Other Causes

0
Number of breast cancer deaths decreased as more years passed after breast cancer diagnosis
For postmenopausal women

SABCS: Breast Cancer Rates Opposite for Estrogen, Estrogen + Progestin

0
In postmenopausal women, breast cancer incidence down with estrogen alone, up with CEE + MPA
Among older men with prostate cancer

Organ Transplant Does Not Worsen Prostate Cancer Outcome

0
No increase in cancer-specific mortality seen in men with prostate cancer who receive organ transplants

American Society of Hematology, Dec. 7-10

0
The 61st American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec....
Stephen Hahn

Hahn Confirmed as New FDA Chief

0
One major challenge facing Hahn is the teen vaping epidemic
Among cancer survivors

Factors Predict Adverse Opioid-Related Outcomes in Cancer Survivors

0
Demographic, cancer, and treatment factors can predict outcomes with high level of discrimination
A diagnostic model can help predict diagnosis of Barrett esophagus in patients with symptomatic gastroesophageal reflux disease

Model May Predict Barrett Esophagus Diagnosis in GERD Patients

0
Model validated for prediction of Barrett esophagus, with eight features showing diagnostic value
For patients with early-stage breast cancer

SABCS: Long-Term Outcomes Good for PBI in Early Breast Cancer

0
10-year ipsilateral breast tumor recurrence rates similar for partial, whole breast irradiation
Not all patients have access to new

Access to High-Cost Targeted Treatments Varies for Lung Cancer

0
Patients treated at a National Cancer Institute-designated center more likely to receive these drugs for lung cancer